ML20148D302: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
Line 17: | Line 17: | ||
=Text= | =Text= | ||
{{#Wiki_filter:}} | {{#Wiki_filter:_ | ||
fr&MMWMMELMWLWM&WLW3(MSMW&WM21QiiT5?LfMMM&WKG?STMM&MfMSMWMMg% | |||
1 NRC Fctr=,374* (} ( j g ,0l 8 41, ( J.S. NUCLE AR REGULATORY COMMIS$10N ( ,/ PAGE } OF 2 PAGES 1 | |||
1 MATERIALS LICENSE Amendment No. 14 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, g 4 | |||
Code of Federal Regulations / Chapter I, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and representations p 1 heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, y 1 source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to n 1 deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This y l license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is 4 subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any , | |||
q conditions specified below. g 1 | |||
Licensee I | |||
) In accordance with letter dated bruar l | |||
1 I' 3. [jena nuyb1 r 1988, !p l 1 Department of Health and Human Services SNM-13^5 is amended in l 1 National Institutes of Health its entirety to read as follows: W i | |||
1 e_ - | |||
l@k l | |||
) | |||
Building 21, Room 110 Bethesda, Maryland 20205 _\, }}M j, 'Ehtr$i @e t | |||
_ _ March 31. 1993 Jg j y (f ' 5. Docket or 7 j s ) Reference No. 070-01366 d 6. Byproduct, source, and/or 1 7. Chemical and/or physical L8. Maximum amount that licensee special nuclear material form 6may possess at any one time f l | |||
@ \ ' /~/ 'under this license l l A. Plutonium (principalQi DN Q2Y | |||
, A.' S,ealed sources, A. 0(75 grams (3 individual 1 radionuclide Pu-238) | |||
T + n ) y[ J T hy{ | |||
. ,1 1 | |||
, sourges not to exceed 250milligramseach) | |||
'~~.v 1 | |||
1 i_ A. /- - , s l 9. Authorized use g em w ll ;hf | |||
.{ | |||
gy jg,g w | |||
e | |||
) . | |||
t j A. As a component of Coratomic'Model s -101 nuclear-1 clinical evaluatiorLpurposeQin acc&da"ndN~ith) "Human'powered; Clinic'ai cardiac Protocol pacemakers for the for 1 Coratomic C-101 Radi6fsotope PoweFed'CiFdiac Pacer,"; dated foyember 1,1975. This pl 1 license authorizes p'ossessioh of'thefpacemaker for 'purpos bi j recovery, storage and'dijsposal but notgrjimplaritation. qsiof explantation, l */ CONDITIONS \~ l | |||
: 10. Licensed material shall be used nip'atdheiati " n 1 Institutes of Health, 1 1 Bethesda, Maryland. | |||
1 !)b j 11. The specified possession limit includes all licensed material possessed by the l 3 | |||
licensee under this license whether in storage, implanted in patients, or otherwise ! | |||
] in use. ! | |||
1 1 12. The licensee shall report to the U.S. Nuclear Regulatory Commission, Region I, i 1 ATTN: Chief, Nuclear Materials Safety and Safeguards Branch, 475 Allendale Road, l King of Prussia, Pennsylvania 19406, within 24 hours of occurrence, the death 5 | |||
of any nuclear pacemaker patient, and any adverse reaction and/or malfunction . | |||
3 involving a pacemaker system, including the leads. A written report giving details I 1 of the adverse reaction and/or malfunction shall be submitted within 30 days. | |||
1 1 13. The licensee shall report to the U.S. Nuclear Regulatory Comission, Region I, k | |||
} ATTN: Chief, Nuclear Materials Safety and Safeguards Branch, 475 Allendale Road, ! | |||
j King of Prussia, Pennsylvania 19406, within 10 days of loss of contact with a nuclear pacemaker patient. ; | |||
8803240001 880311 'e g g* ' ' | |||
w _; g g a.m o W 7mmx=r-- -er -e-dr.- A E,-m @w .-- - | |||
j | |||
7 N R GU A O 2 License number > | |||
MATERIALS LICENSE S -1345 h 1 | |||
g ,g, SUPPL,EMENTARY SHEET g, g i Amendment No. 14 i ) | |||
h CONDITIONS k (Continued) h | |||
: 14. The licensee shall continue patient follow-up and replacement procedures for the i nuclear pacemaker during the life of the patient. Procedures for recovery and I authorized disposal of the nuclear pacemaker by return to the manufacturer shall be i followed upon the death of the patient. i i | |||
: 15. Sealed sources or detector cells containing licensed material shall not be opened , | |||
or sources removed from source holders or detector cells by the licensee, g | |||
^ ,.s .. | |||
l | |||
: 16. The licensee may transport licensed , material sin accordance with the provisions ! | |||
of 10 CFR Part 71, "Packaging and Transportation-of Radioactive Material". h | |||
( r | |||
: 17. Except as specifically'provided otherwise in this license, the licensee shall l conduct its program _in accordance with the statements, repr_esentations, and p procedures contained in the documents including any enclosures, listed below. > | |||
The Nuclear Regulatory Coninission's regulations shall- govern' unless the state- > | |||
ments, representations an'd procedures in the licensee's application and corre- $ | |||
spondence are more' restrictive than the. regulations.:' , | |||
/ -, . i rp, , [ , .. x> : | |||
A. Letter dated February 15, 1973 * | |||
(, | |||
: 8. Letter dated September 10, 1975._,_ u , L C. Letter datdd - August '17,1976 J.i [* /, c, ' & | |||
,f , '< 'T D. | |||
Letter dated ' March:29; 1978 : N-QF h)nyg[' k f | |||
E. LetterreceivedMayi28;1982hl cf F. | |||
Letterdated(q Februarft l,;1988% 6 t j fMh %w 'WljaD -' y y | |||
O. | |||
s< ' | |||
~px | |||
,7.y c Lt | |||
(' | |||
/. &. a g'Q 3> ;i y | |||
, 'LQlV'$ . | |||
lg | |||
.n - | |||
m | |||
- .- e o | |||
) | |||
2 | |||
[V W | |||
W W | |||
= | |||
W 6 | |||
6 V | |||
V | |||
\ $ | |||
I For the U.S. Nuclear Regulatory Commission original Signed Byf p 1 | |||
11 MAR 1988 ey 3 - e 3onaasen g oate Nuclear Materials Safety and g Safeguards Branch, Region I g King of Prussia, Pennsylvania 19406 F( | |||
1 __ | |||
* w wcsms w wm wwme wwmmmm2r2sunnutw wwar w mwerT&we M5 T"EremMTXE2"JLT&T. | |||
l}} |
Latest revision as of 17:51, 21 July 2020
ML20148D302 | |
Person / Time | |
---|---|
Site: | 07001366 |
Issue date: | 03/11/1988 |
From: | Johansen J NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION I) |
To: | |
Shared Package | |
ML20148D305 | List: |
References | |
NUDOCS 8803240001 | |
Download: ML20148D302 (2) | |
Text
_
fr&MMWMMELMWLWM&WLW3(MSMW&WM21QiiT5?LfMMM&WKG?STMM&MfMSMWMMg%
1 NRC Fctr=,374* (} ( j g ,0l 8 41, ( J.S. NUCLE AR REGULATORY COMMIS$10N ( ,/ PAGE } OF 2 PAGES 1
1 MATERIALS LICENSE Amendment No. 14 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, g 4
Code of Federal Regulations / Chapter I, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and representations p 1 heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, y 1 source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to n 1 deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This y l license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is 4 subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any ,
q conditions specified below. g 1
Licensee I
) In accordance with letter dated bruar l
1 I' 3. [jena nuyb1 r 1988, !p l 1 Department of Health and Human Services SNM-13^5 is amended in l 1 National Institutes of Health its entirety to read as follows: W i
1 e_ -
l@k l
)
Building 21, Room 110 Bethesda, Maryland 20205 _\,M j, 'Ehtr$i @e t _ _ March 31. 1993 Jg j y (f ' 5. Docket or 7 j s ) Reference No. 070-01366 d 6. Byproduct, source, and/or 1 7. Chemical and/or physical L8. Maximum amount that licensee special nuclear material form 6may possess at any one time f l
@ \ ' /~/ 'under this license l l A. Plutonium (principalQi DN Q2Y , A.' S,ealed sources, A. 0(75 grams (3 individual 1 radionuclide Pu-238)
T + n ) y[ J T hy{
. ,1 1 , sourges not to exceed 250milligramseach) '~~.v 1
1 i_ A. /- - , s l 9. Authorized use g em w ll ;hf
.{
gy jg,g w e
) .
t j A. As a component of Coratomic'Model s -101 nuclear-1 clinical evaluatiorLpurposeQin acc&da"ndN~ith) "Human'powered; Clinic'ai cardiac Protocol pacemakers for the for 1 Coratomic C-101 Radi6fsotope PoweFed'CiFdiac Pacer,"; dated foyember 1,1975. This pl 1 license authorizes p'ossessioh of'thefpacemaker for 'purpos bi j recovery, storage and'dijsposal but notgrjimplaritation. qsiof explantation, l */ CONDITIONS \~ l
- 10. Licensed material shall be used nip'atdheiati " n 1 Institutes of Health, 1 1 Bethesda, Maryland.
1 !)b j 11. The specified possession limit includes all licensed material possessed by the l 3 licensee under this license whether in storage, implanted in patients, or otherwise !
] in use. !
1 1 12. The licensee shall report to the U.S. Nuclear Regulatory Commission, Region I, i 1 ATTN: Chief, Nuclear Materials Safety and Safeguards Branch, 475 Allendale Road, l King of Prussia, Pennsylvania 19406, within 24 hours of occurrence, the death 5 of any nuclear pacemaker patient, and any adverse reaction and/or malfunction . 3 involving a pacemaker system, including the leads. A written report giving details I 1 of the adverse reaction and/or malfunction shall be submitted within 30 days. 1 1 13. The licensee shall report to the U.S. Nuclear Regulatory Comission, Region I, k
} ATTN: Chief, Nuclear Materials Safety and Safeguards Branch, 475 Allendale Road, !
j King of Prussia, Pennsylvania 19406, within 10 days of loss of contact with a nuclear pacemaker patient. ; 8803240001 880311 'e g g* ' ' w _; g g a.m o W 7mmx=r-- -er -e-dr.- A E,-m @w .-- - j
7 N R GU A O 2 License number > MATERIALS LICENSE S -1345 h 1 g ,g, SUPPL,EMENTARY SHEET g, g i Amendment No. 14 i ) h CONDITIONS k (Continued) h
- 14. The licensee shall continue patient follow-up and replacement procedures for the i nuclear pacemaker during the life of the patient. Procedures for recovery and I authorized disposal of the nuclear pacemaker by return to the manufacturer shall be i followed upon the death of the patient. i i
- 15. Sealed sources or detector cells containing licensed material shall not be opened ,
or sources removed from source holders or detector cells by the licensee, g
^ ,.s ..
l
- 16. The licensee may transport licensed , material sin accordance with the provisions !
of 10 CFR Part 71, "Packaging and Transportation-of Radioactive Material". h ( r
- 17. Except as specifically'provided otherwise in this license, the licensee shall l conduct its program _in accordance with the statements, repr_esentations, and p procedures contained in the documents including any enclosures, listed below. >
The Nuclear Regulatory Coninission's regulations shall- govern' unless the state- > ments, representations an'd procedures in the licensee's application and corre- $ spondence are more' restrictive than the. regulations.:' ,
/ -, . i rp, , [ , .. x> :
A. Letter dated February 15, 1973 * (,
- 8. Letter dated September 10, 1975._,_ u , L C. Letter datdd - August '17,1976 J.i [* /, c, ' &
,f , '< 'T D.
Letter dated ' March:29; 1978 : N-QF h)nyg[' k f E. LetterreceivedMayi28;1982hl cf F. Letterdated(q Februarft l,;1988% 6 t j fMh %w 'WljaD -' y y O. s< '
~px ,7.y c Lt
('
/. &. a g'Q 3> ;i y , 'LQlV'$ .
lg
.n -
m
- .- e o )
2 [V W W W
=
W 6 6 V V \ $ I For the U.S. Nuclear Regulatory Commission original Signed Byf p 1 11 MAR 1988 ey 3 - e 3onaasen g oate Nuclear Materials Safety and g Safeguards Branch, Region I g King of Prussia, Pennsylvania 19406 F( 1 __
- w wcsms w wm wwme wwmmmm2r2sunnutw wwar w mwerT&we M5 T"EremMTXE2"JLT&T.
l}}